Trump Expands Drug Pricing Agreements with Nine New Firms
By Editor • August 31, 2026 • 1 min read
President Trump has secured new pricing agreements with nine additional drug manufacturers, expanding a previous initiative with 17 companies.
The latest signatories—Alcon, Astellas, BeOne, BridgeBio, CSL, Sun Pharma, Kyowa Kirin, Teva, and UCB—committed to providing U.S. patients with medications at prices comparable to those in other countries and to offer Medicaid access at favorable rates. In exchange, some firms may avoid tariffs.
Source: www.statnews.com
